Skip to the page
pepts.wiki

We are not doctors and nothing here is medical advice. Always consult a medical professional first. Why we say this

Studied in peopleStub

Orexin A

Hypothalamic neuropeptide (hypocretin-1)

A 33 amino acid neuropeptide that promotes wakefulness; its loss causes narcolepsy type 1.

Reconstitution calculator

At a glance

Studied in people

There are published studies in people. It is not a licensed medicine in the United States or the European Union.

This page is a stub

The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.

How strong is the evidence

How far it has climbed

Every medicine climbs the same ladder. Most compounds never reach the top, and where one stands says how much its claims can carry.

  1. Licensed medicine

    A regulator has reviewed the trials and licensed it for a named use.

  2. Phase 3

    Large randomized trials, often thousands of people, against placebo or a standard treatment.

  3. Phase 2

    Mid-sized trials that measure dose against effect in people with the condition.

  4. Phase 1 and early human studies: Orexin A

    First studies in people: safety, and how the body handles it.

  5. Cells and animals

    Laboratory and animal work. An animal result is not a result in people.

980
papers on PubMed
338
of them in people
11
randomized trials
30
reviews

A count says how much has been published, not what it found. Counted on PubMed: 2026-11-16

Handling and reconstitution

From powder to a measured sample

The same four steps for any lyophilized vial. Laboratory handling, not use in a person.

  1. 1. Read the vial

    The label gives the mass of peptide in the vial, in milligrams. That number is the start of every calculation.

  2. 2. Add the diluent

    A measured volume of diluent goes in slowly, down the glass. Swirl gently; shaking can damage a peptide.

  3. 3. Work out the strength

    Concentration is mass divided by volume: 10 mg in 2 mL is 5 mg per mL.

  4. 4. Measure the sample

    Volume is the mass wanted divided by the concentration. On a U-100 syringe, 1 mL is 100 units.

The calculator below does the arithmetic and shows its working.

As powder

General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.

In solution

Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.

This is general practice for lyophilized peptides, not data on Orexin A itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage

Reconstitution calculator

Opens on vial sizes common for research peptides. Change any number. How the arithmetic works

Draw to

10 units

0.1 mL on a U-100 syringe

Concentration
2.5 mg/mL
Each unit holds
25 mcg
Samples in the vial
20
Sample
250 mcg

5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of Orexin A; no amount here is a recommendation.

Orexin A: on PubMed

What PubMed held for Orexin A on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.

980
papers
338
in humans
15
clinical trials
11
randomized trials
2012: 35 papers122013: 31 papers2014: 48 papers142015: 49 papers2016: 52 papers162017: 52 papers2018: 59 papers182019: 47 papers2020: 49 papers202021: 47 papers2022: 44 papers222023: 23 papers2024: 31 papers242025: 34 papers2026: 28 papers so far26
Papers per year, 2012 to 2026. The most in one year: 59.

Most relevant on PubMed

Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.

  1. Plasma Orexin-A Levels in Patients With Schizophrenia: A Systematic Review and Meta-Analysis

    ReviewLi S, Zhang R, Hu S, et al. Frontiers in psychiatry, 2022. PMID 35693955

  2. Orexin-A in Patients With Lewy Body Disease: A Systematic Review and Meta-Analysis

    Meta-analysisGan J, Chen Z, Han J, et al. Frontiers in endocrinology, 2021. PMID 34867809

  3. Exploring the role of Orexin-A neuropeptide in Parkinson's disease: A systematic review and meta-analysis

    Meta-analysisSuresh V, Bardhan M, Ghosh S, et al. Clinical neurology and neurosurgery, 2024. PMID 38781804

  4. Intranasal orexin A modulates sympathetic vascular tone: a pilot study in healthy male humans

    Randomized trialMeusel M, Voß J, Krapalis A, et al. Journal of neurophysiology, 2022. PMID 35044844

  5. Associations of plasma hypocretin-1 with metabolic and reproductive health: Two systematic reviews of clinical studies

    ReviewDunietz GL, Vanini G, Shannon C, et al. Sleep medicine reviews, 2020. PMID 32259696

  6. Circulating Concentrations of Orexin A Predict Left Ventricular Myocardial Remodeling

    TrialIbrahim NE, Rabideau DJ, Gaggin HK, et al. Journal of the American College of Cardiology, 2016. PMID 27855816

  7. 16-mer hypocretin-1/orexin-A in cerebrospinal fluid to diagnose narcolepsy

    StudyVialaret J, Hirtz C, Lotierzo M, et al. Sleep, 2025. PMID 40801283

  8. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers

    StudyBorgland SL, Chang SJ, Bowers MS, et al. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009. PMID 19741128

Search used: ("orexin-A"[ti] OR "orexin A"[ti] OR "hypocretin-1"[ti]). Run it on PubMed

Research links

Also in Cognitive